Results 191 to 200 of about 5,771,550 (333)

What to Expect After a Commercial Fishery Ban? Long Term Fish Size and Biomass Trends in Two Productive Water Bodies With Contrasting Management Regimes

open access: yesAquatic Conservation: Marine and Freshwater Ecosystems, Volume 36, Issue 2, February 2026.
ABSTRACT Commercial fishing is often assumed to have greater impacts than recreational fishing, and many fisheries assessments overlook the latter. Yet, numerous coastal and freshwater fish populations are subject to both fishing types and environmental pressures, all influencing biomass, body size and community structure and making management outcomes
Eglė Jakubavičiūtė   +3 more
wiley   +1 more source

Uncovering Putative Bacterial Pathogens in Lakes in Aotearoa New Zealand Using Environmental DNA

open access: yesEcology and Evolution, Volume 16, Issue 2, February 2026.
Aquatic diseases threaten ecological, social, cultural and economic values. An eDNA survey of 287 lakes in Aotearoa New Zealand detected 412 potential pathogens. Key drivers of putative pathogen presence included high‐productivity exotic grassland and elevated nutrient levels.
Javier Atalah   +6 more
wiley   +1 more source

Association of Anti‐Inflammatory Dietary Adherence With Biomarkers and Gut Microbiota Related to Colorectal Cancer Risk: A Retrospective Study

open access: yesFood Science &Nutrition, Volume 14, Issue 2, February 2026.
This retrospective study evaluates whether greater adherence to an anti‐inflammatory diet is associated with biomarkers and gut microbiota profiles linked to reduced colorectal cancer risk. The study seeks to clarify how dietary patterns influence inflammation and gut microbiota, providing insights to guide effective prevention strategies for ...
Hantao Wang, Yunjie Shi, Wei Wang, Xu Li
wiley   +1 more source

Fertility and Early Embryonic Development Toxicity of hzVSF‐v13 in Sprague–Dawley Rats

open access: yesJournal of Applied Toxicology, Volume 46, Issue 2, Page 560-568, February 2026.
ABSTRACT Humanized virus suppressing factor–variant 13 (hzVSF‐v13), a monoclonal IgG4 antibody, is a potential therapeutic candidate for COVID‐19. Although fertility and embryonic developmental toxicity studies are crucial for the safety evaluation of new drugs, the toxicological profile of hzVSF‐v13 remains unexplored.
Ji‐Seong Jeong   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy